Clearwater Paper Corp. Q1 2011 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2011. Clearwater Paper Corporation manufactures pulp-based products, including consumer tissue, paperboard, and wood products. A significant development during this period was the full integration of the Cellu Tissue Holdings, Inc. acquisition, completed on December 27, 2010, which added nine U.S. facilities and one Canadian facility to the company's footprint.
Key Financial Metrics
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Net Sales | $465.8 million | $330.6 million |
| Net Earnings | $5.6 million | $0.5 million |
| Diluted EPS | $0.47 | $0.04 |
| Operating Income | $23.5 million | $10.6 million |
| Operating Margin | 5.1% | 3.2% |
| EBITDA | $41.7 million | $22.4 million |
| Cash from Operations | $38.6 million | $71.0 million |
| Total Debt (Long-term + Current) | $538.7 million | $539.1 million |
| Cash & Short-term Investments | $159.2 million | $145.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 40.9% year-over-year, driven primarily by the inclusion of Cellu Tissue operations and higher selling prices for pulp, paperboard, and wood products.
- Profitability: Net earnings surged to $5.6 million from $0.5 million. Operating income more than doubled to $23.5 million.
- Segment Performance:
- Consumer Products: Sales rose 95.4% to $269.3 million due to Cellu Tissue volume, though operating income declined 47% to $13.8 million due to lower margins and higher pulp/transportation costs.
- Pulp and Paperboard: Sales increased slightly (2.0%) to $196.6 million. Operating income improved significantly from a loss of $7.9 million to a profit of $15.6 million, aided by higher prices and lower maintenance costs.
- Cost Structure: Cost of sales as a percentage of net sales improved to 89.1% from 91.3%. However, interest expense increased $7.0 million to $11.3 million due to the 2010 Senior Notes issuance.
- Cash Flow: Operating cash flow decreased 45.6% to $38.6 million, largely due to the absence of a $39.4 million government tax credit refund received in Q1 2010 and an $8.5 million pension contribution in Q1 2011.
Outlook, Risks, and Management Commentary
- Capital Expenditures: The company is constructing new tissue facilities in Shelby, North Carolina, with a total estimated cost of $260–$280 million. $30.3 million has been incurred to date. Total 2011 CapEx is expected to be $175–$180 million.
- Tax Rate: The effective tax rate for Q1 2011 was 52.2%, impacted by discrete items including state tax structure changes and interest on uncertain tax positions. The estimated annual effective tax rate for 2011 is 35.8%.
- Liquidity: The company maintains a $125 million revolving credit facility with $116.6 million available. Management believes cash flows and borrowing capacity are sufficient for the next 12 months.
- Risks: Key risks include integration challenges with Cellu Tissue, volatility in wood fiber and energy costs, labor disruptions, and the cyclical nature of the forest products industry.
- Unusual Items: Q1 2010 included a $4.4 million reversal of deferred tax assets due to the Affordable Care Act, which did not recur in 2011. Q1 2011 included a $11.4 million maintenance shutdown cost at the Idaho facility.
Investor Verification Checklist
- Verify the integration progress and cost synergies of the Cellu Tissue acquisition.
- Monitor the timeline and cost overruns for the Shelby, North Carolina expansion project.
- Track wood fiber and energy cost trends, which represent significant portions of operating costs.
- Review the status of the $375 million 2018 Senior Notes and compliance with debt covenants (leverage and fixed charge coverage).
- Assess the impact of the revised intersegment pulp transfer accounting methodology on segment comparability.